» Authors » Norma Cameli

Norma Cameli

Explore the profile of Norma Cameli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 298
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Bennardo L, Passante M, Cameli N, Cristaudo A, Patruno C, Nistico S, et al.
Bioengineering (Basel) . 2021 Nov; 8(11). PMID: 34821719
Morphological and functional skin alterations secondary to the action of ionizing radiation are well documented. In addition to its application in the medical field, ionizing radiation represents a public health...
12.
Berardesca E, Cameli N
Dermatol Ther . 2021 Oct; 34(6):e15160. PMID: 34655146
Vitamin E is a powerful lipophilic antioxidant that protects membranes from lipid peroxidation, and consequently, oxidative damage. Oxidative stress plays a role in the development of neurodegenerative diseases. Vitamin E...
13.
Silvestri M, Cristaudo A, Morrone A, Messina C, Bennardo L, Nistico S, et al.
Drug Saf . 2021 May; 44(7):725-732. PMID: 33959899
Three cyclin-dependent kinases 4/6, including palbociclib, ribociclib, and abemaciclib, have been approved for the treatment of patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer....
14.
Cameli N, Silvestri M, Mariano M, Berardesca E
J Cosmet Dermatol . 2021 May; 20 Suppl 1:32-35. PMID: 33934476
Background: Silicon is an abundant element in the human body and plays an important role in the skin, taking part in the synthesis of collagen and glycosaminoglycans. The use of...
15.
Cristaudo A, Pigliacelli F, Sperati F, Orsini D, Cameli N, Morrone A, et al.
Skin Res Technol . 2021 Mar; 27(5):810-813. PMID: 33651467
Background: Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by pruritus, xerosis, and skin barrier dysfunction. Skin barrier alteration is associated with an increase in trans-epidermal water loss...
16.
Mariano M, Donati P, Cameli N, Pigliacelli F, Morrone A, Cristaudo A
J Breast Cancer . 2021 Feb; 24(1):117-121. PMID: 33634626
Ribociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor that has been approved in combination with endocrine therapy for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative advanced or...
17.
Berardesca E, Cameli N, Piacentini M, Veraldi S, Celleno L
J Cosmet Dermatol . 2020 Dec; 20(8):2527-2530. PMID: 33347705
Background: Treatment of unwanted body hair is a challenging area in cosmetic dermatology. Topical soy isoflavones and derivatives or eflornithine have been utilized in dermatocosmetology for their estrogenic and antiandrogenic...
18.
Pigliacelli F, Dona M, Giglio A, Cameli N, Morrone A, Zaccarelli M, et al.
Int J Dermatol . 2020 Oct; 59(11):1391-1392. PMID: 33078398
No abstract available.
19.
Cameli N, Mariano M, Zanniello R, Berardesca E
Dermatol Ther . 2020 Aug; 33(6):e14224. PMID: 32833275
Rosacea is a very common chronic facial dermatosis characterized by a multiphase evolution. Inflammation is an important reaction in rosacea not only due to inflammatory reactions to cutaneous microorganisms, such...
20.
Latini A, Alei L, Magri F, Eibenschutz L, Cota C, Dona M, et al.
AIDS . 2020 Jul; 34(10):1570-1572. PMID: 32675567
: In the cART era, the incidence of AIDS-defining cancers decreased, whereas a persistence of non-AIDS-defining cancers has been observed. In particular, concerning the risk of melanoma and nonmelanoma skin...